On the other hand, mutations of the CTNNB1 have been associated with other malignant tumors, such as melanoma, renal cell carcinoma, hepatocarcinoma, medulloblastoma, colon cancer, lung cancer, and ovarian cancer, among others [31, 38, 39]. This evidence concerns the gene CTNNB1 and melanoma.